Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Smoking, MFN1, and NLRP3 Levels in Gum Fluid Across Periodontal Health and Disease

Official title: ASSOCİATİON BETWEEN SMOKİNG AND GİNGİVAL CREVİCULAR FLUİD MFN1 AND NLRP3 LEVELS İN INDİVİDUALS WİTH PERİODONTAL HEALTH OR PERİODONTİTİS

Run by Abant Izzet Baysal University · NCT07826728 · Data updated 2026-11-12

This study tests whether smoking changes MFN1 and NLRP3 protein levels in the fluid around the gums for adults with or without periodontitis.

More Smoking trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment88 (estimated)
SponsorAbant Izzet Baysal University
Academic / other
Locations1 site (Bolu, Central)
StatusRecruiting
StartedAugust 15, 2026
Main results expectedOctober 15, 2026
Study endsNovember 15, 2026
Registry record updatedSeptember 17, 2026
Trial IDNCT07826728 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 25–65 years old with either periodontal health or stage III–IV periodontitis, who are current smokers (≥10 cigarettes/day for ≥5 years) or non-smokers, and able to provide informed consent.

Probably not a fit

Individuals with mild or undiagnosed periodontal conditions outside the defined groups or those unable to provide informed consent may see no direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares the levels of MFN1 and NLRP3 in gingival crevicular fluid across four groups: healthy nonsmokers, healthy smokers, nonsmokers with periodontitis, and smokers with periodontitis. Adults 25–65 years old provide medical and smoking histories and undergo a periodontal exam, with gum-fluid samples collected before treatment. The collected samples are analyzed for MFN1 and NLRP3, and results are examined in relation to periodontal measurements and smoking history. The aim is to understand how smoking and periodontal disease together influence these inflammatory and cellular-process proteins.

Why it matters

Potential benefit: If associations are found, results could inform risk stratification and pave the way for targeted biomarker research in periodontal health and disease.

How similar studies have gone: Previous studies have linked smoking and inflammatory markers in periodontal disease, but this study tests MFN1 and NLRP3 specifically in gingival crevicular fluid.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18-65 years. At least 20 natural teeth. For the periodontal health groups: periodontal health on an intact periodontium, with probing depths ≤3 mm, full-mouth bleeding on probing \<10%, and no interdental clinical attachment loss or radiographic bone loss attributable to periodontitis.

For the periodontitis groups: Stage III or Stage IV periodontitis according to the 2017 periodontal disease classification.

For the smoking groups: current cigarette smoking of at least 10 cigarettes per day for at least 5 years.

For the nonsmoking groups: fewer than 100 cigarettes smoked during the lifetime and no current use of tobacco or nicotine products.

Provision of written informed consent.

Exclusion Criteria:

* ormer cigarette smoking. Use of electronic cigarettes, heated tobacco products, nicotine pouches, or nicotine replacement products.

Uncontrolled diabetes, immunodeficiency, autoimmune or chronic inflammatory disease, or a serious systemic disease that may affect periodontal or mitochondrial responses.

Pregnancy or breastfeeding. Use of antibiotics, systemic corticosteroids, immunosuppressive medications, or regular anti-inflammatory medications within the previous 3 months.

Periodontal treatment within the previous 6 months. Acute oral infection, periodontal abscess, or local pathology affecting the sampling sites.

Gingival crevicular fluid samples contaminated with blood or saliva, or insufficient for ELISA analysis.

Where it's running

  • Faculty of Dentistry, Bolu Abant İzzet Baysal University, Department of Periodontics
    Bolu, Central, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.